Andre Pereira Fraga Figueiredo
Director/Board Member at GENETETHER THERAPEUTICS INC.
Net worth: 64 077 $ as of 2024-05-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| R. Geoffrey Sargent | M | 70 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 years |
| Daren Graham | M | 52 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 years |
| Garner William | M | 58 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 6 years |
| Roland Boivin | M | 57 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 years |
| Philip Jull | M | 64 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 years |
| Jean Jen | F | 37 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Peter Sampson | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 6 | 85.71% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Andre Pereira Fraga Figueiredo
- Personal Network
